Alkon Daniel L. 4/A
4/A · Synaptogenix, Inc. · Filed Dec 1, 2022
Insider Transaction Report
Form 4/AAmended
Alkon Daniel L.
DirectorChief Scientific Officer
Transactions
- Award
Common Stock, par value $0.0001 per share
2021-07-13+43,750→ 55,234 total
Footnotes (1)
- [F1]This filing amends the Form 4, filed on July 15, 2021 by Mr. Alkon to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended.